Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

[Triclocarban antibacterial activity on resistant staphylococci, streptococci, and enterococci].

Drugeon HB, Rouveix B, Michaud-Nerard A.

Med Mal Infect. 2012 Jun;42(6):276-9. doi: 10.1016/j.medmal.2012.04.004. Epub 2012 May 22. French.

PMID:
22626523
2.

In vitro antibacterial activity of ceftobiprole against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints.

Lascols C, Legrand P, Mérens A, Leclercq R, Muller-Serieys C, Drugeon HB, Kitzis MD, Reverdy ME, Roussel-Delvallez M, Moubareck C, Brémont S, Miara A, Gjoklaj M, Soussy CJ.

Int J Antimicrob Agents. 2011 Mar;37(3):235-9. doi: 10.1016/j.ijantimicag.2010.11.035. Epub 2011 Feb 4.

3.

In vitro antibacterial activity of doripenem against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints.

Lascols C, Legrand P, Mérens A, Leclercq R, Armand-Lefevre L, Drugeon HB, Kitzis MD, Muller-Serieys C, Reverdy ME, Roussel-Delvallez M, Moubareck C, Lemire A, Miara A, Gjoklaj M, Soussy CJ.

Eur J Clin Microbiol Infect Dis. 2011 Apr;30(4):475-82. doi: 10.1007/s10096-010-1117-6. Epub 2010 Nov 19. Review.

4.

Correlation between the VITEK2 system and cefoxitin disk diffusion for the daily detection of oxacillin resistance in a large number of clinical Staphylococcus aureus isolates.

Bemer P, Juvin ME, Le Gargasson G, Drugeon H, Reynaud A, Corvec S.

Eur J Clin Microbiol Infect Dis. 2010 Jun;29(6):745-7. doi: 10.1007/s10096-010-0920-4. Epub 2010 Apr 6.

PMID:
20372955
5.

Overproduction of K1 enzyme in Klebsiella oxytoca clinical isolates against ceftazidime, cefepime and ceftobiprole.

Corvec S, Cremet L, Lepelletier D, Reynaud A, Drugeon H.

J Chemother. 2009 Jun;21(3):365-6. No abstract available.

PMID:
19567362
6.

Significance of Propionibacterium acnes-positive samples in spinal instrumentation.

Bémer P, Corvec S, Tariel S, Asseray N, Boutoille D, Langlois C, Tequi B, Drugeon H, Passuti N, Touchais S.

Spine (Phila Pa 1976). 2008 Dec 15;33(26):E971-6. doi: 10.1097/BRS.0b013e31818e28dc.

PMID:
19092607
7.

Clinical efficacy and time to symptom resolution of 5-day telithromycin versus 10-day amoxicillin-clavulanate in the treatment of acute bacterial sinusitis.

Desrosiers M, Ferguson B, Klossek JM, Drugeon H, Mösges R.

Curr Med Res Opin. 2008 Jun;24(6):1691-702. doi: 10.1185/03007990802133914.

PMID:
18559163
8.

[Monitoring of antibiotic resistance of gram negative anaerobes].

Singer E, Calvet L, Mory F, Muller C, Chomarat M, Bézian MC, Bland S, Juvenin ME, Drugeon H, Fosse T, Goldstein F, Jaulhac B, Monteil H, Marchandin H, Jean-Pierre H, Dubreuil L.

Med Mal Infect. 2008 May;38(5):256-63. doi: 10.1016/j.medmal.2008.03.007. Epub 2008 May 14. French.

PMID:
18482812
9.

Antibiotic innovation may contribute to slowing the dissemination of multiresistant Streptococcus pneumoniae: the example of ketolides.

Opatowski L, Temime L, Varon E, Leclercq R, Drugeon H, Boëlle PY, Guillemot D.

PLoS One. 2008 May 7;3(5):e2089. doi: 10.1371/journal.pone.0002089. Erratum in: PLoS ONE. 2008;3(5). doi: 10.1371/annotation/968c3453-14aa-4300-b743-cdb4f4c90a36. Leclerc, Roland [corrected to Leclercq, Roland].

10.

Long-term evolution of a nosocomial outbreak of Pseudomonas aeruginosa producing VIM-2 metallo-enzyme.

Corvec S, Poirel L, Espaze E, Giraudeau C, Drugeon H, Nordmann P.

J Hosp Infect. 2008 Jan;68(1):73-82.

PMID:
18079018
11.

Real-time PCR assay for the detection and quantification of Legionella pneumophila in environmental water samples: utility for daily practice.

Morio F, Corvec S, Caroff N, Le Gallou F, Drugeon H, Reynaud A.

Int J Hyg Environ Health. 2008 Jul;211(3-4):403-11. Epub 2007 Aug 27.

PMID:
17720622
12.

Identification of the novel narrow-spectrum beta-lactamase SCO-1 in Acinetobacter spp. from Argentina.

Poirel L, Corvec S, Rapoport M, Mugnier P, Petroni A, Pasteran F, Faccone D, Galas M, Drugeon H, Cattoir V, Nordmann P.

Antimicrob Agents Chemother. 2007 Jun;51(6):2179-84. Epub 2007 Apr 9.

13.

Genetics and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-23 in Acinetobacter baumannii.

Corvec S, Poirel L, Naas T, Drugeon H, Nordmann P.

Antimicrob Agents Chemother. 2007 Apr;51(4):1530-3. Epub 2007 Jan 12.

14.

[Clinical aspects and management of patients with tuberculous meningitis. Retrospective analysis from 1994 to 2005].

Bémer P, Boutoille D, Lepelletier D, Chamoux C, Guitton C, Drugeon H.

Rev Pneumol Clin. 2006 Sep;62(4):223-9. French.

PMID:
17075546
15.

Increased resistance to beta-lactams in a Klebsiella pneumoniae strain: role of a deletion downstream of the Pribnow box in the blaSHV-1 promoter.

Corvec S, Caroff N, Cosano D, Dauvergne S, Drugeon H, Reynaud A.

Int J Antimicrob Agents. 2006 Oct;28(4):308-12. Epub 2006 Sep 7.

PMID:
16956751
16.

Biological cost of fluoroquinolone resistance in Escherichia coli implicated in polyclonal infection.

Bémer P, Corvec S, Guitton C, Giraudeau C, Le Gargasson G, Espaze E, Drugeon H.

Pathol Biol (Paris). 2007 Jul;55(6):288-91. Epub 2006 Aug 1.

PMID:
16884861
17.

Emergence of carbapenem-hydrolysing metallo-beta-lactamase VIM-1 in Pseudomonas aeruginosa isolates in France.

Corvec S, Poirel L, Decousser JW, Allouch PY, Drugeon H, Nordmann P.

Clin Microbiol Infect. 2006 Sep;12(9):941-2. No abstract available.

18.

Cervical spondylitis due to Neisseria meningitidis.

Mendes S, Bémer P, Corvec S, Faure A, Redon H, Drugeon HB.

Eur J Intern Med. 2006 May;17(3):204-5.

PMID:
16618455
19.

[Efficacy and safety of extended-release clarithromycin (5-day short-course) vs telithromycin, in acute bacterial exacerbation of chronic bronchitis].

Perronne C, Drugeon H, Zuck P, Filipecki J, Vincent-Lacaze N, Goldfarb G, Léophonte P.

Med Mal Infect. 2005 Oct;35(10):507-15. Epub 2005 Oct 18. French.

PMID:
16239090
21.

Surgical-site infection after cardiac surgery: incidence, microbiology, and risk factors.

Lepelletier D, Perron S, Bizouarn P, Caillon J, Drugeon H, Michaud JL, Duveau D.

Infect Control Hosp Epidemiol. 2005 May;26(5):466-72.

PMID:
15954485
22.

[Vaccination failure: case report of Haemophilus influenzae b meningitis in a 14-month-old child].

Corvec S, Hazart I, Reynaud A, Picherot G, Drugeon H.

Pathol Biol (Paris). 2005 Mar;53(2):92-6. French.

PMID:
15708653
23.

[How can antibiotics' capacity of selecting bacterial resistance be assessed].

Andremont A, Cohen R, Drugeon H.

Med Mal Infect. 2004 Jun;34 Suppl 1:S109-11. French. No abstract available.

PMID:
15676225
24.

Influence of carbon dioxide on the MIC of telithromycin for Streptococcus pneumoniae: an in vitro-in vivo study.

Batard E, Juvin ME, Jacqueline C, Bugnon D, Caillon J, Potel G, Drugeon HB.

Antimicrob Agents Chemother. 2005 Jan;49(1):464-6.

25.

[An example of simulation for a better understanding of PK/PD relationship of antibiotics].

Le Normand Y, Ganiere-Monteil C, Drugeon H, Abbas S, Mazeas M, Kergueris MF.

Pathol Biol (Paris). 2004 Dec;52(10):597-601. French.

PMID:
15596309
26.

[Prevention of COPD exacerbations: conducting a clinical trial evaluating the benefits of inhaled steroids].

Chabot F, Devillier P, Drugeon H, Dusser D, Fournier M, Gaillard J, Grouin JM, Housset B, Huchon G, Léophonte P, Muir JF, Raffy O, Tonnel AB, Tremolieres F, Zück P, Attali V, Boucot I, Chemali-Hudry J, Daniloski M; Groupe REFLEX BPCO.

Rev Mal Respir. 2004 Sep;21(4 Pt 1):685-8. French. No abstract available.

PMID:
15536368
27.

Randomized comparison of serum teicoplanin concentrations following daily or alternate daily dosing in healthy adults.

Rouveix B, Jehl F, Drugeon H, Brumpt I, Caulin E.

Antimicrob Agents Chemother. 2004 Jul;48(7):2394-9.

28.

[Treatment of exacerbations of chronic obstructive pulmonary disease with pristinamycin].

Léophonte P, Chidiac C, Drugeon HB, Strabach S, Cabrillac-Rives S, Chone C, Dellatolas F, Safran C.

Rev Mal Respir. 2004 Apr;21(2 Pt 1):261-71. French.

PMID:
15211234
30.

Activity of linezolid against Gram-positive cocci isolated in French hospitals as determined by three in-vitro susceptibility testing methods.

Muller-Serieys C, Drugeon HB, Etienne J, Lascols C, Leclercq R, Nguyen J, Soussy CJ.

Clin Microbiol Infect. 2004 Mar;10(3):242-6.

31.

Multicenter evaluation of the MB/BACT system for susceptibility testing of Mycobacterium tuberculosis.

Bemer P, Bodmer T, Munzinger J, Perrin M, Vincent V, Drugeon H.

J Clin Microbiol. 2004 Mar;42(3):1030-4.

32.

Which strategies follow from the surveillance of multidrug-resistant bacteria to strengthen the control of their spread? A French experience.

Lepelletier D, Perron S, Huguenin H, Picard M, Bemer P, Caillon J, Juvin ME, Drugeon HB.

Infect Control Hosp Epidemiol. 2004 Feb;25(2):162-4.

PMID:
14994943
33.
34.

Comparison of two RT-PCR methods for quantifying ampC specific transcripts in Escherichia coli strains.

Corvec S, Caroff N, Espaze E, Marraillac J, Drugeon H, Reynaud A.

FEMS Microbiol Lett. 2003 Nov 21;228(2):187-91.

35.

In vitro antibacterial activity of moxifloxacin against hospital isolates: a multicentre study.

Soussy CJ, Nguyen J, Goldstein F, Dabernat H, Andremont A, Leclercq R, Drugeon H, Cavallo P, Chardon H, Etienne J, Rio Y, Courvalin P.

Clin Microbiol Infect. 2003 Oct;9(10):997-1005.

36.

[Should we screen for colonization to control the spread of multidrug resistant bacteria?].

Lepelletier D, Perron S, Huguenin H, Picard M, Bemer P, Caillon J, Juvin ME, Drugeon H.

Pathol Biol (Paris). 2003 Oct;51(8-9):464-8. French.

PMID:
14568591
37.

AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains.

Corvec S, Caroff N, Espaze E, Giraudeau C, Drugeon H, Reynaud A.

J Antimicrob Chemother. 2003 Oct;52(4):629-35. Epub 2003 Sep 1.

PMID:
12951337
38.

In vitro activities of a new lipopeptide, HMR 1043, against susceptible and resistant gram-positive isolates.

Bemer P, Juvin ME, Bryskier A, Drugeon H.

Antimicrob Agents Chemother. 2003 Sep;47(9):3025-9.

39.

Combination of quinupristin-dalfopristin and gentamicin against methicillin-resistant Staphylococcus aureus: experimental rabbit endocarditis study.

Batard E, Jacqueline C, Boutoille D, Hamel A, Drugeon HB, Asseray N, Leclercq R, Caillon J, Potel G, Bugnon D.

Antimicrob Agents Chemother. 2002 Jul;46(7):2174-8.

40.

Legionella pneumophila Arthritis: use of medium specific for Mycobacteria for isolation of L. pneumophila in culture of articular fluid specimens.

Bemer P, Leautez S, Ninin E, Jarraud S, Raffi F, Drugeon H.

Clin Infect Dis. 2002 Jul 1;35(1):E6-7. Epub 2002 Jun 4.

PMID:
12060893
41.
42.
43.

[Antibacterial activity of urine after administration of ofloxacin for 5 days].

Drugeon H, Veyries ML, Levacher M, Garnier M, Aymard G, Giroud JP, Rouveix B.

Therapie. 2000 Nov-Dec;55(6):691-7. French.

PMID:
11234464
44.

[Antibiogram Committee of the French Microbiology Society. Report 2000-2001].

Soussy CJ, Carret G, Cavallo JD, Chardon H, Chidiac C, Choutet P, Courvalin P, Dabernat H, Drugeon H, Dubreuil L, Goldstein F, Jarlier V, Leclercq R, Nicolas-Chanoine MH, Philippon A, Quentin C, Rouveix B, Sirot J.

Pathol Biol (Paris). 2000 Nov;48(9):832-71. French. No abstract available.

PMID:
11141919
45.

In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes: influences of resistance mechanisms and methodological factors.

Bemer-Melchior P, Juvin ME, Tassin S, Bryskier A, Schito GC, Drugeon HB.

Antimicrob Agents Chemother. 2000 Nov;44(11):2999-3002.

46.

Comparison of the in vitro activities of rifapentine and rifampicin against Mycobacterium tuberculosis complex.

Bemer-Melchior P, Bryskier A, Drugeon HB.

J Antimicrob Chemother. 2000 Oct;46(4):571-6.

PMID:
11020254
47.

Bacteremia due to Dietzia maris in an immunocompromised patient.

Bemer-Melchior P, Haloun A, Riegel P, Drugeon HB.

Clin Infect Dis. 1999 Nov;29(5):1338-40. No abstract available.

PMID:
10524995
49.

Inactivation of Mycobacterium tuberculosis for DNA typing analysis.

Bemer-Melchior P, Drugeon HB.

J Clin Microbiol. 1999 Jul;37(7):2350-1.

50.

Diagnosis of extrapulmonary tuberculosis by a commercial polymerase chain reaction kit.

Bemer-Melchior P, Germaud P, Drugeon HB.

Pathol Biol (Paris). 1998 Oct;46(8):597-603.

PMID:
9871931

Supplemental Content

Loading ...
Support Center